Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke.
Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke.
复制标题
DOI:
10.1523/jneurosci.0698-11.2011
复制
发表时间:
2011-06-15
期刊:
影响因子:
--
通讯作者:
Troy CM
中科院分区:
文献类型:
--
作者:
Akpan N;Serrano-Saiz E;Zacharia BE;Otten ML;Ducruet AF;Snipas SJ;Liu W;Velloza J;Cohen G;Sosunov SA;Frey WH 2nd;Salvesen GS;Connolly ES Jr;Troy CM
Despite extensive research to develop an effective neuroprotective strategy for the treatment of ischemic stroke, therapeutic options remain limited. While caspase-dependent death is thought to play a prominent role in neuronal injury, direct evidence of active initiator caspases in stroke and the functional relevance of this activity have not previously been shown. Employing an unbiased caspase-trapping technique in vivo, we isolated active caspase-9 from ischemic rat brain within 1 hour of reperfusion. Pathogenic relevance of active caspase-9 was shown by intranasal delivery of a novel cell membrane-penetrating highly specific inhibitor for active caspase-9 at 4 hours post-reperfusion (hpr). Pharmacologic caspase-9 inhibition provided neurofunctional protection and established caspase-6 as its downstream target. The temporal and spatial pattern of expression demonstrates that neuronal caspase-9 activity induces caspase-6 activation mediating axonal loss by 12hpr followed by neuronal death within 24hpr. Collectively, these results support selective inhibition of these specific caspases as an effective therapeutic strategy for stroke.